MediWound (MDWD) Income from Non-Controlling Interests (2013 - 2016)

MediWound's (MDWD) quarterly Income from Non-Controlling Interests came in at $3000.0 in Q2 2016, up 200.0% quarter-over-quarter from $1000.0 in Q4 2015.

MediWound (MDWD) Income from Non-Controlling Interests (2013 - 2016) Analysis & Trends

MediWound's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $3000.0 for Q2 2016.

  • On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to $3000.0 in Q2 2016; TTM through Jun 2016 was $4000.0, a 50.0% decrease from a year earlier, with the FY2015 full-year figure at $2000.0, down 85.71% from the prior year.
  • Income from Non-Controlling Interests improved to $3000.0 in Q2 2016 per MDWD's latest filing, from $1000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $34000.0 in Q3 2014 and bottomed at -$27000.0 in Q4 2014.
  • The 4-year median for Income from Non-Controlling Interests is $1000.0 (2015), against an average of -$1444.4.
  • Biggest YoY gain for Income from Non-Controlling Interests was 525.0% in 2014; the steepest drop was 12.5% in 2014.
  • Year by year, Income from Non-Controlling Interests stood at -$24000.0 in 2013, then decreased by 12.5% to -$27000.0 in 2014, then surged by 103.7% to $1000.0 in 2015, then soared by 200.0% to $3000.0 in 2016.
  • Per Business Quant, the three latest MDWD Income from Non-Controlling Interests figures stand at $3000.0 (Q2 2016), $1000.0 (Q4 2015), and $1000.0 (Q1 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn - -
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn - -
3 Akari Therapeutics 1,021.31 Bn 1,021.31 Bn - -
4 BeOne Medicines 467.89 Bn 463.10 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.19 Bn 61.44 Bn 3.31 Bn -
7 Belite Bio 63.46 Bn 63.46 Bn - -
8 Argenx Se 55.64 Bn 50.45 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.67 Bn 34.66 Bn 959.66 Mn -
10 MediWound 167.52 Mn 162.72 Mn 278,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2016 3,000.00
Dec 31, 2015 1,000.00
Mar 31, 2015 1,000.00
Dec 31, 2014 -27,000.00
Sep 30, 2014 34,000.00
Jun 30, 2014 17,000.00
Mar 31, 2014 -10,000.00
Dec 31, 2013 -24,000.00
Sep 30, 2013 -8,000.00